Jesper Johannesen - Concepedia

Author

Jesper Johannesen

Also Known As

A Januszewski, Flemming Pociot, H. B. Mortensen, J Johannesen, J. JOHANNESEN, J. Johannesen, J.O. Johannesen, JESPER JOHANNESEN, Jesper Johannesen, Jesper Johannesen (418472)

167

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Steno Diabetes Centers Herlev Hospital University of Copenhagen Copenhagen University Hospital Odense University Hospital

About

Jesper Johannesen is an author at Steno Diabetes Centers specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.1K
2	Health Sciences	6	6	185
3	Public Health	5	5	215
4	Natural Sciences	3	3	85
5	Social Sciences	1	1	51

Jesper Johannesen

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity Allan E. Karlsen, Sif G. Rønn, Karen Lindberg, Proceedings of the National Academy of Sciences Immune RegulationImmunologyCell DeathImmunologic MechanismSocs-3 Prevention	2001	141
The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes Birthe Susanne Olsen, Anne Katrin Sjølie, Philip Hougaard, Journal of Diabetes and its Complications Type 1Diabetic RetinopathyDiabetes ManagementOphthalmologyMedicine	2004	115
A 6-year nationwide cohort study of glycaemic control in young people with Type 1 diabetes Birthe Sussane Olsen, Anne-Katrin Sjølie, Philip Hougaard, Journal of Diabetes and its Complications Metabolic SyndromeType 1Young PeopleDiabetes EpidemiologyDiabetes Management	2000	102
Residual β-Cell Function 3–6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents Jesper Sørensen, Jesper Johannesen, Flemming Pociot, Diabetes Care	2013	87
Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1? Steffen Helqvist, Barbara S. Polla, Jesper Johannesen, Diabetologia InflammationCytokineIslet TransplantationAutoimmune DiseaseImmunology	1991	85
Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus Birthe Susanne Olsen, Jesper Johannesen, K. Borch‐Johnsen, Diabetic Medicine	1999	85
Improved metabolic outcome in a Danish diabetic paediatric population aged 0-18 yr: results from a nationwide continuous Registration Jannet Svensson, Jesper Johannesen, Henrik B. Mortensen, Pediatric Diabetes Nationwide Continuous RegistrationObesityMetabolic SyndromeBody CompositionHematology	2009	74
Genetic Susceptibility Markers in Danish Patients with Type 1 (Insulin-Dependent) Diabetes-Evidence for Polygenecity in Man Flemming Pociot, Kjersti S. Rosnningen, Regine Bergholdt, Autoimmunity	1994	67
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis Peter Simm, Jesper Johannesen, Julie Briody, Bone Zoledronic AcidBone HealthOsteoarthritisBone TurnoverOsteoporosis	2011	58
IDDM12 ( <i>CTLA4</i> ) on 2q33 and <i>IDDM13</i> on 2q34 in Genetic Susceptibility to Type 1 Diabetes (Insulin-dependent) Z. M. Larsen, Ole Peter Kristiansen, Eugènia Mato, Autoimmunity	1999	57

Page 1